These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 20851083

  • 21. Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.
    Okamoto S, Yoshii H, Ishikawa T, Akagi T, Akashi M, Takahashi M, Yamanishi K, Mori Y.
    Vaccine; 2008 Jan 30; 26(5):589-94. PubMed ID: 18180081
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y, Ye J, Cao S, Xiao S, Zhao Q, Liu X, Jin M, Chen H.
    J Gene Med; 2009 Feb 30; 11(2):150-9. PubMed ID: 19040206
    [Abstract] [Full Text] [Related]

  • 25. Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.
    Schuller E, Jilma B, Voicu V, Golor G, Kollaritsch H, Kaltenböck A, Klade C, Tauber E.
    Vaccine; 2008 Aug 12; 26(34):4382-6. PubMed ID: 18599165
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial.
    Yun KW, Lee HJ, Kang JH, Eun BW, Kim YJ, Kim KH, Kim NH, Hong YJ, Kim DH, Kim HM, Cha SH.
    BMC Infect Dis; 2015 Jan 08; 15():7. PubMed ID: 25567119
    [Abstract] [Full Text] [Related]

  • 31. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
    Cao L, Fu S, Gao X, Li M, Cui S, Li X, Cao Y, Lei W, Lu Z, He Y, Wang H, Yan J, Gao GF, Liang G.
    PLoS Negl Trop Dis; 2016 May 08; 10(5):e0004686. PubMed ID: 27139722
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.
    Chanthavanich P, Limkittikul K, Sirivichayakul C, Chokejindachai W, Hattasingh W, Pengsaa K, Surangsrirat S, Srisuwannaporn T, Kaewma B, Yoksan S, Jun G, Zhumu B.
    Hum Vaccin Immunother; 2018 Apr 03; 14(4):900-905. PubMed ID: 29227177
    [Abstract] [Full Text] [Related]

  • 34. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.
    Lobigs M, Pavy M, Hall RA, Lobigs P, Cooper P, Komiya T, Toriniwa H, Petrovsky N.
    J Gen Virol; 2010 Jun 03; 91(Pt 6):1407-17. PubMed ID: 20130134
    [Abstract] [Full Text] [Related]

  • 35. Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: using PRNT50 as an endpoint for immunogenicity.
    Reisler RB, Danner DK, Gibbs PH.
    Vaccine; 2010 Mar 11; 28(12):2436-41. PubMed ID: 20060946
    [Abstract] [Full Text] [Related]

  • 36. Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study.
    Muangchana C, Henprasertthae N, Nurach K, Theppang K, Yoocharoen P, Varinsathien P, Techathawat S, Sanohsieng S, Anantapreecha S.
    Vaccine; 2012 Jan 05; 30(2):361-7. PubMed ID: 22075090
    [Abstract] [Full Text] [Related]

  • 37. Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells.
    Appaiahgari MB, Vrati S.
    Vaccine; 2004 Sep 09; 22(27-28):3669-75. PubMed ID: 15315846
    [Abstract] [Full Text] [Related]

  • 38. A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine.
    Puthanakit T, Aurpibul L, Yoksan S, Sirisanthana T, Sirisanthana V.
    Vaccine; 2010 Aug 16; 28(36):5900-2. PubMed ID: 20600498
    [Abstract] [Full Text] [Related]

  • 39. Immunogenicity of a recombinant MVA and a DNA vaccine for Japanese encephalitis virus in swine.
    Nam JH, Cha SL, Cho HW.
    Microbiol Immunol; 2002 Aug 16; 46(1):23-8. PubMed ID: 11911185
    [Abstract] [Full Text] [Related]

  • 40. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.
    Fan YC, Chen JM, Chiu HC, Chen YY, Lin JW, Shih CC, Chen CM, Chang CC, Chang GJ, Chiou SS.
    PLoS Negl Trop Dis; 2012 Aug 16; 6(9):e1834. PubMed ID: 23029592
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.